🚀

MRK Merck & Company Inc

Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals  | NYSE, MegaCap |  Last Price: 123.82 | 2026-02-27 | Atrp: 2.43

Sat 21 Feb 2026 to Fri 27 Feb 2026: Score 8

MetricPreviousNewChangeInterpretation
✅Enterprise Value/EBITDA14.678711.6669▼ -20.52%Bullish. Lower is better. Significant improvement
Enterprise value to earnings before interest, taxes, depreciation
✅Short Ratio2.372.03▼ -14.35%Bullish. Lower is better. Moderate improvement
✅EBITDA$28797.33M$29105M▲ 1.07%Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow
Earnings before interest, taxes, depreciation, and amortization
✅Book Value20.84521.258▲ 1.98%Bullish. Higher is better. Slight increase; stock now trades closer to book value
Net asset value of the company per share
✅Price Sales TTM4.69734.5836▼ -2.42%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Price Book MRQ5.81185.7108▼ -1.74%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value$324.5B$329.73B▲ 1.61%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Short Percent1.29%1.26%▼ -2.33%Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌Enterprise Value/Revenue4.99155.0719▲ 1.61%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Return On Assets TTM13.76%12.04%▼ -12.5%Bearish. Higher is better. Return on assets TTM growth slowing.
Efficiency in generating profits from total assets

Sat 14 Feb 2026 to Sat 21 Feb 2026: Score -3

MetricPreviousNewChangeInterpretation
❌PEG Ratio2.7952.8459▲ 1.82%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE23.201923.6407▲ 1.89%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Book MRQ5.70795.8118▲ 1.82%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue4.90874.9915▲ 1.69%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA14.435114.6787▲ 1.69%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
✅Enterprise Value$319.12B$324.5B▲ 1.69%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Institutional Ownership80.082%81.049%▲ 1.21%Bullish. Higher is better. Slight increase; continued strong interest from big investors
Percentage held by institutions like mutual funds

Sat 07 Feb 2026 to Sat 14 Feb 2026: Score 1

MetricPreviousNewChangeInterpretation
✅Short Percent1.51%1.29%▼ -14.57%Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅Wall Street Target Price121.2692124.8846▲ 2.98%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Short Ratio2.452.37▼ -3.27%Bullish. Lower is better. Slight improvement
❌PEG Ratio2.65222.795▲ 5.38%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE22.026423.2019▲ 5.34%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings

Sat 31 Jan 2026 to Sat 07 Feb 2026: Score -31

MetricPreviousNewChangeInterpretation
❌PEG Ratio0.80122.6522▲ 231.03%Bearish. Lower is better. Extreme increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Quarterly Earnings Growth YOY871%-191%▼ -122.18%Bearish. Higher is better. Quarterly earnings growth YOY turned from growth to decline; signs of deterioration.
Year-over-year growth in quarterly earnings
❌Forward PE9.132422.0264▲ 141.19%Bearish. Lower is better. Extreme decline
Stock price divided by expected future earnings
❌EPS Estimate Current Year8.93585.1466▼ -42.4%Bearish. Higher is better. Significant decrease; reduced outlook for current year earnings
Expected earnings per share this year
❌Price Book MRQ4.56345.7323▲ 25.61%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue3.93544.9281▲ 25.22%Bearish. Lower is better. Significant decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA9.998314.4923▲ 44.95%Bearish. Lower is better. Significant decline
Enterprise value to earnings before interest, taxes, depreciation
❌Operating Margin TTM40.8%32.56%▼ -20.2%Bearish. Higher is better. Operating margin TTM growth slowing.
Percentage of revenue left after operating expenses
❌EBITDA$31523M$28797.33M▼ -8.65%Bearish. Higher is better. Decline in earnings before interest, taxes, depreciation, and amortization; indicates weaker operational cash flow
Earnings before interest, taxes, depreciation, and amortization
❌Earnings Per Share7.77.28▼ -5.45%Bearish. Higher is better. Slight decline in earnings per share
Profit allocated to each outstanding share
❌Profit Margin29.63%28.08%▼ -5.23%Bearish. Higher is better. Profit margin growth slowing.
Percentage of revenue that turns into profit
❌Return On Equity TTM39.49%37.17%▼ -5.87%Bearish. Higher is better. Return on equity TTM growth slowing.
Efficiency in generating profits from shareholders' equity
❌Price Sales TTM4.28794.6847▲ 9.25%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Wall Street Target Price117.5769121.2692▲ 3.14%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Revenue TTM$64235M$65011M▲ 1.21%Bullish. Higher is better. Slight top-line expansion
Total revenue over the trailing twelve months
✅Revenue Per Share TTM25.55925.932▲ 1.46%Bullish. Higher is better. Slight improvement
Revenue generated per outstanding share over the trailing twelve months
✅Enterprise Value$292.06B$320.38B▲ 9.7%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Quarterly Revenue Growth YOY41%51%▲ 35.14%Bullish. Higher is better. Quarterly revenue growth YOY growth accelerating.
Year-over-year growth in quarterly revenue
✅EPS Estimate Next Year5.6639.8087▲ 73.21%Bullish. Higher is better. Substantial raised expectations for further out
Expected earnings per share next year

Sat 24 Jan 2026 to Sat 31 Jan 2026: Score 11

MetricPreviousNewChangeInterpretation
✅PEG Ratio1.17190.8012▼ -31.63%Bullish. Lower is better. Significant decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅Forward PE11.83439.1324▼ -22.83%Bullish. Lower is better. Significant improvement
Stock price divided by expected future earnings
✅Price Book MRQ5.17854.5634▼ -11.88%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue4.54063.9354▼ -13.33%Bullish. Lower is better. Moderate improvement
Enterprise value divided by revenue
✅Enterprise Value/EBITDA10.54479.9983▼ -5.18%Bullish. Lower is better. Slight improvement
Enterprise value to earnings before interest, taxes, depreciation
✅Wall Street Target Price115.3333117.5769▲ 1.95%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Earnings Per Share7.567.7▲ 1.85%Bullish. Higher is better. Slight increase in earnings per share
Profit allocated to each outstanding share
❌Price Sales TTM4.20664.2879▲ 1.93%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Short Percent1.46%1.51%▲ 3.42%Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌EPS Estimate Next Year6.1835.663▼ -8.41%Bearish. Higher is better. Slight lowered expectations for further out
Expected earnings per share next year
❌Short Ratio2.322.45▲ 5.6%Bearish. Lower is better. Slight decline

Sat 17 Jan 2026 to Sat 24 Jan 2026: Score -3

MetricPreviousNewChangeInterpretation
❌EPS Estimate Next Year6.84546.183▼ -9.68%Bearish. Higher is better. Slight lowered expectations for further out
Expected earnings per share next year
❌PEG Ratio1.14631.1719▲ 2.23%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE11.574111.8343▲ 2.25%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
✅Wall Street Target Price113.4815115.3333▲ 1.63%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock

Sat 10 Jan 2026 to Sat 17 Jan 2026: Score 6

MetricPreviousNewChangeInterpretation
✅Short Percent1.67%1.46%▼ -12.57%Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅PEG Ratio1.16911.1463▼ -1.95%Bullish. Lower is better. Slight decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅Forward PE11.806411.5741▼ -1.97%Bullish. Lower is better. Slight improvement
Stock price divided by expected future earnings
✅Price Sales TTM4.2984.2319▼ -1.54%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Price Book MRQ5.3135.2096▼ -1.95%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue4.64924.5657▼ -1.8%Bullish. Lower is better. Slight improvement
Enterprise value divided by revenue
✅Enterprise Value/EBITDA10.796810.603▼ -1.79%Bullish. Lower is better. Slight improvement
Enterprise value to earnings before interest, taxes, depreciation
❌Enterprise Value$298.64B$293.28B▼ -1.8%Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments
Market capitalization plus debt minus cash
❌EPS Estimate Next Year7.4566.8454▼ -8.19%Bearish. Higher is better. Slight lowered expectations for further out
Expected earnings per share next year

Sat 03 Jan 2026 to Sat 10 Jan 2026: Score -10

MetricPreviousNewChangeInterpretation
❌PEG Ratio1.10871.1691▲ 5.45%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌EPS Estimate Next Year8.27247.456▼ -9.87%Bearish. Higher is better. Slight lowered expectations for further out
Expected earnings per share next year
❌Forward PE11.198211.8064▲ 5.43%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Book MRQ5.03875.313▲ 5.44%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue4.42784.6492▲ 5%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA10.282610.7968▲ 5%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
❌Price Sales TTM4.13934.298▲ 3.83%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Wall Street Target Price110.0396113.3333▲ 2.99%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Enterprise Value$284.42B$298.64B▲ 5%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Sun 21 Dec 2025 to Sat 03 Jan 2026: Score -14

MetricPreviousNewChangeInterpretation
❌Short Percent1.43%1.67%▲ 16.78%Bearish. Lower is better. Moderate increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌PEG Ratio1.06481.1087▲ 4.12%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE10.752711.1982▲ 4.14%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Sales TTM3.93094.1393▲ 5.3%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ4.83915.0387▲ 4.12%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Short Ratio2.172.34▲ 7.83%Bearish. Lower is better. Slight decline
❌Enterprise Value/Revenue4.26664.4278▲ 3.78%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA9.908410.2826▲ 3.78%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
✅Enterprise Value$274.07B$284.42B▲ 3.78%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash